Colorectal Cancer Screening Might Need to Start Sooner Than You Thought

An updated recommendation from the American Cancer Society lowers the age to begin routine screening for colorectal cancer to 45.

12:22 PM

Author | Shelley Zalewski

OR Room

Thinking you could wait till your 50th birthday to worry about colorectal cancer? Maybe not.

New guidelines from the American Cancer Society recognize recent studies that have found increasing rates of colorectal cancer among younger people. In response, they lowered the recommended age to begin screening from 50 to 45.

LISTEN UP: Add the new Michigan Medicine News Break to your Alexa-enabled device, or subscribe to our daily audio updates on iTunes, Google Play and Stitcher.

"Research from our institution and others confirms that colon and rectal cancer are the fastest growing cancer types among people under age 50," says colorectal surgeon Karin Hardiman, M.D, Ph.D. 

Hardiman, surgical director of the Rogel Cancer Center's Multidisciplinary Colorectal Cancer Clinic, cites a recent study cautioning that early onset colorectal cancer also tends to be more advanced when diagnosed and more likely to involve the rectum. 

"We regularly see younger patients who have never had a colonoscopy, despite symptoms of more advanced disease like bleeding. Earlier screening might have detected their cancers before they experienced symptoms. For prevention, we know that colonoscopy, which identifies suspicious polyps and guides their removal, prevents about 90 percent of colorectal cancers," she says.

Regardless of the recommended screening age, anyone with worrisome symptoms, such as bleeding, pain or changes in bowel habits, should talk with their doctor about further evaluation with colonoscopy.

See also: Should Young People Get a Colon Cancer Screening? It Depends on Their Risk

"The important message is that people should have a conversation with their doctor about their family history of cancer to examine their risk for colorectal cancer and determine the best age to start screening," says Elena Stoffel, M.D., MPH, assistant professor of internal medicine at the Michigan Medicine and director of the Cancer Genetics Clinic at the Rogel Cancer Center.

MORE FROM MICHIGAN: Sign up for our weekly newsletter

These individuals are considered at higher risk for colorectal cancer and should talk with their doctor about screening with colonoscopy before age 50.

  • A personal history of colorectal cancer or certain types of polyps
  • A personal history of inflammatory bowel diseases 
  • A family history of colorectal cancer
  • A confirmed or suspected hereditary colorectal cancer syndrome
  • A personal history of radiation to the abdomen or pelvic area to treat a prior cancer

Screening recommendations

Adults at average risk of colorectal cancer should undergo regular screening with either a high‐sensitivity stool‐based test or a structural (visual) examination, depending on patient preference and test availability.

Screening options include:

  • Fecal immunochemical test – annually
  • High‐sensitivity, guaiac‐based fecal occult blood test – annually
  • Multitarget stool DNA test – every three years
  • Colonoscopy – every 10 years
  • Computed tomography colonography – every five years
  • Flexible sigmoidoscopy – every five years

All positive results from screening tests other than colonoscopy should be followed up with timely colonoscopy.

Additional American Cancer Society recommendations:

  • Average‐risk adults in good health with a life expectancy of more than 10 years continue screening through age 75
  • Screening decisions for average-risk individuals ages 76-85 should be based on patient preferences, life expectancy, health status and prior screening history
  • Individuals older than age 85 at average risk for colorectal cancer do not need screening

For questions about colorectal cancer screening or to schedule an appointment, call the Cancer AnswerLine at 800-865-1125.


More Articles About: Preventative health and wellness Colorectal Cancer Cancer: Cancer Types
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories person with stomach pain purple and grey coloring and at home stool test
Health Lab
When to use an at-home colorectal cancer screening test instead of a colonoscopy
What to know about an at-home colorectal cancer screening test versus a colonoscopy
doctor in colon with flashlight and polyp
Health Lab
COVID-19 and colonoscopies: 5 things to know
As more adults are being diagnosed with colorectal cancer at a younger age, a specialist explains why it’s not safe to put off your screening, even during the pandemic.
colon interior polyps in stomach lining drawing
Health Lab
The New Age to Get Your Colorectal Cancer Screening
The U.S. Preventive Services Task Force has lowered the recommended age of colorectal cancer screenings to 45 due to a rise in colorectal cancer cases among the younger population.
cancer cell blue yellow
Health Lab
Widening inequality seen where cancer clinical trials are available
The availability of clinical trials of new treatments for cancer varies greatly by geography, and a new study shows more socially vulnerable areas have far fewer.
Exterior photograph of an urgent care clinic
Health Lab
Thinking outside the doctor’s office: How older adults use urgent care & in-store clinics
In the past two years, 60% of people age 50 to 80 have visited an urgent care clinic, or a clinic based in a retail store, workplace or vehicle, according to new findings from the University of Michigan National Poll on Healthy Aging.
Blue image of a microscopic helix strand
Health Lab
Researchers discover urine based test to detect head and neck cancer
At-home test can detect tumor DNA fragments in urine samples, providing a non-invasive alternative to traditional blood-based biomarker tests